Sernova (TSE:SVA) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Sernova Corp., a biotech company advancing cell therapies for chronic diseases, has announced the appointment of biotech veteran David Paterson Ph.D. to its Board of Directors. Paterson’s extensive experience in corporate development and his biopharma industry knowledge are expected to bolster Sernova’s growth and its innovative Cell Pouch System technology, particularly in the type 1 diabetes sector.
For further insights into TSE:SVA stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue